Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brown-Forman Corporation Class B (BF.B) vs Oscar Health Inc (OSCR) Price & Performance

Brown-Forman Corporation Class BTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Brown-Forman Corporation Class B vs Oscar Health Inc — how do they compare? Brown-Forman Corporation Class B trades at $27.83, while Oscar Health Inc trades at $28.69 (market cap $8.63B). The key difference: Oscar Health Inc is trading nearer its 52-week high, Brown-Forman Corporation Class B nearer its low. Which is the better fit depends on your goals.

BF.BOSCR
Sector
Consumer StaplesHealth
52-Week High
$31.26$32.18
52-Week Low
$22.80$10.85
Market Cap
$8.63B
Enterprise Value
$4.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Brown-Forman Corporation Class B

BF.B trades at $28.19, down 1.16% for the day, with technical indicators showing a bullish trend supported by moving averages. The stock has demonstrated strong earnings performance, beating expectations in three of the last four quarters. Analyst sentiment is mixed with a 25% buy rating amid limited recent news coverage.

The outlook remains cautiously optimistic given recent earnings strength, though the divided analyst consensus and lack of current financial metrics present valuation challenges. Key risks include execution consistency and market volatility, while institutional positioning will be critical for sustained momentum.

Oscar Health Inc

OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.

Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.

Returns comparison

Trailing returns across standard periods

About Brown-Forman Corporation Class B

Brown-Forman is the largest U.S.-domiciled producer of distilled spirits. The firm reports only a single operating segment, and whiskey represents its primary business driver, generating roughly three-quarters of sales, undergirded by the Jack Daniel's brand as well as bourbons such as Woodford Reserve and Old Forrester. Notable nonwhiskey offerings include tequilas such as el Jimador and Herradura. The firm operates globally, with products sold in more than 170 countries, and adapts its route-to-consumer model depending on regulation as well as the prevailing competitive dynamics in a given market. For example, it sells through distributors in the U.S. but operates its own logistics apparatus in many other countries. The company remains under the control of the Brown family.

Read more on BF.B

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR